Engrail Therapeutics


Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.

Employees

11-50

Links


Org chart

Vikram Sudarsan
President, CEO & Board Member
Collapse
Rex E. Bosen
Acting CFO
Stephen Cunningham
Chief Development Officer & Board Member
Anil Vootkur
VP, Corporate Development
Eve M. Taylor, PhD
Executive Vice President, Clinical Program Management And Regulatory Affairs
Penelope Przekop
Data Protection Officer | Executive QA Consultant
Paul Cayer
Chief Financial Officer
Quentin McCubbin
Chief Technical Officer

Board & advisors

Karoly Nikolich
Board Member
Tony Ho
Board Member


Offices